Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Australian disappointed she was not notified by Channel 7 about new season of The Voice
    • Satire

    Australian disappointed she was not notified by Channel 7 about new season of The Voice

    A group of reality television lovers have slammed Channel 7 for their lack of promotion around the The Voice which launched last night, claiming they were never notified of the new season.  Leader of the group Television for Reality And Social Heroes (TRASH), Martina Martinez was particularly scathing of the network’s owner Seven West Media

    Read More
    Public
  • Who’s selling from the inside? – A look at key company shareholder movements
    • Opinion

    Who’s selling from the inside? – A look at key company shareholder movements

    Our Insider & Shareholders’ Transactions Monthly aims to understand the ‘actual’ sentiment of insiders (such as company directors and officers) and major shareholders (such as founders with significant holdings), towards a Company by analysing their transaction data, tracking and dissecting actual purchases and divestment of stock by these key stakeholders. In this report, we neatly

    Read More
    Public
  • US markets showing signs of breaking higher
    • News

    US markets showing signs of breaking higher

    Overnight the SP500 and Nasdaq closed in the all-time high territory. The Dow is still testing resistance. Technically we are seeing signs of continuation on both the Nasdaq and SP500 charts. Tonight, we will see further Jobs data. There are a few large names to report tonight and next week, but most of the US

    Read More
    Public
  • MDMA usage at University is through the roof as Emyria takes aim at mental health
    • News

    MDMA usage at University is through the roof as Emyria takes aim at mental health

    Harbouring more MDMA than music festival goers, the University of Western Australia (UWA) is leading the way in research around the use of MDMA as a psychedelic medication. Clinical drug development and care delivery company Emyria (ASX: EMD) has today announced a partnership with UWA, confirming access to their library of MDMA- like compounds developed

    Read More
    Public
  • RE/Max signs with Openn as home buyers flock to online auctions
    • News

    RE/Max signs with Openn as home buyers flock to online auctions

    Within the digitisation of our lives which was accelerated by a global pandemic, interest from home buyers with a preference for online auctions continues to grow with real estate network RE/Max the latest to partner with property tech company Openn Negotiation (ASX: OPN) and their online auction platform.  Despite the pandemic-enforced lockdowns which have limited

    Read More
    Public
  • Pharmaxis enters final dosing round of revolutionary cancer treatment drug
    • News

    Pharmaxis enters final dosing round of revolutionary cancer treatment drug

    Tackling a cancer treatment market estimated to be worth USD $1 billion per annum, drug development company Pharmaxis (ASX: PXS) has entered the final dosing of their Phase 1c trials in the study of a potential new treatment for bone marrow cancer, myelofibrosis. The third and final stage of dosing follows successful first and secondRead More
    Public
  • «
  • ‹
  • 474
  • 475
  • 476
  • 477
  • 478
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.